Apiam Animal Health Limited
Apiam Animal Health Limited (AHX.AX) Financial Performance & Income Statement Overview
Review Apiam Animal Health Limited (AHX.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Apiam Animal Health Limited (AHX.AX) Income Statement & Financial Overview
View the income breakdown for Apiam Animal Health Limited AHX.AX across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $100.29M | $104.36M | $98.04M | $93.72M |
| Cost of Revenue | $77.44M | $85.87M | $85.86M | $77.08M |
| Gross Profit | $22.85M | $18.49M | $12.18M | $16.63M |
| Gross Profit Ratio | $0.23 | $0.18 | $0.12 | $0.18 |
| R&D Expenses | $202000.00 | $198000.00 | $206000.00 | $204000.00 |
| SG&A Expenses | $0.00 | $11.24M | $11.15M | $11.09M |
| Operating Expenses | $202000.00 | $11.24M | $10.83M | $11.09M |
| Total Costs & Expenses | $77.64M | $97.11M | $96.69M | $88.17M |
| Interest Income | $0.00 | $0.00 | $2.24M | $1.53M |
| Interest Expense | $2.88M | $2.64M | $2.24M | $1.53M |
| Depreciation & Amortization | $3.36M | $5.82M | $5.41M | $4.82M |
| EBITDA | $9.13M | $13.08M | $6.75M | $10.36M |
| EBITDA Ratio | $0.09 | $0.13 | $0.07 | $0.11 |
| Operating Income | $22.65M | $7.25M | $1.34M | $5.54M |
| Operating Income Ratio | $0.23 | $0.07 | $0.01 | $0.06 |
| Other Income/Expenses (Net) | -$20.24M | -$2.64M | -$2.24M | -$1.53M |
| Income Before Tax | $2.41M | $4.61M | -$900000.00 | $4.01M |
| Income Before Tax Ratio | $0.02 | $0.04 | -$0.009 | $0.04 |
| Income Tax Expense | $761000.00 | $1.39M | -$225000.00 | $1.22M |
| Net Income | $1.65M | $3.28M | -$621000.00 | $2.90M |
| Net Income Ratio | $0.02 | $0.03 | -$0.006 | $0.03 |
| EPS | $0.009 | $0.02 | -$0.004 | $0.02 |
| Diluted EPS | $0.009 | $0.02 | -$0.004 | $0.02 |
| Weighted Avg Shares Outstanding | $179.35M | $178.09M | $177.96M | $172.37M |
| Weighted Avg Shares Outstanding (Diluted) | $183.32M | $180.66M | $177.96M | $174.94M |
Over the last four quarters, Apiam Animal Health Limited's revenue moved from $93.72M in Q2 2023 to $100.29M in Q4 2024. Operating income in Q4 2024 was $22.65M, with a strong operating margin of 23%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Apiam Animal Health Limited remained robust at $9.13M, reflecting operational efficiency. Net income dropped to $1.65M, with an EPS of $0.009. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan